Rowlands M G, Foster A B, Mann J, Pietrzak B, Wilkinson J, Coombes R C
Drug Development Section, CRC Laboratory, Institute of Cancer Research, Sutton, Surrey, UK.
Steroids. 1987 Apr-May;49(4-5):371-82. doi: 10.1016/0039-128x(87)90011-0.
Twenty-three synthetic analogues of 4-androstene-3,17-dione (androstenedione) have been evaluated as inhibitors of human placental microsomal aromatase enzyme. Among the most potent of these compounds were the 4-hydroxy, 6 alpha-fluoro, 6 beta-fluoro, and 4-fluoroandrostenediones and 4-fluoro-19-nor-4-androstene-3,17-dione. 4-Hydroxy-4-androstene-3,17-dione (4HAD) is an irreversible inhibitor of aromatase in vitro, whereas the four fluoro analogues are reversible inhibitors. 4HAD and 4-fluoro-4-androstene-3,17-dione caused significant regression of the nitrosomethylurea-induced mammary tumor in rats, but the other fluoro derivatives were inactive.
已对23种4-雄烯-3,17-二酮(雄烯二酮)的合成类似物作为人胎盘微粒体芳香化酶抑制剂进行了评估。这些化合物中最有效的是4-羟基、6α-氟、6β-氟和4-氟雄烯二酮以及4-氟-19-去甲-4-雄烯-3,17-二酮。4-羟基-4-雄烯-3,17-二酮(4HAD)在体外是芳香化酶的不可逆抑制剂,而四种氟类似物是可逆抑制剂。4HAD和4-氟-4-雄烯-3,17-二酮可使大鼠亚硝基甲基脲诱导的乳腺肿瘤显著消退,但其他氟衍生物无活性。